Genomics Market Outlook, Geographical Segmentation, Industry Size & Share, and Comprehensive Analysis to 2025

This market intelligence report on Genomics market evaluates and presents a worldwide market scenario along with market estimates, insights and projections for a timeframe of 2020-2025. This examination the market dynamics that are foreseen to influence the market growth in a coming couple of years. Also, the report clarifies the effect of the key factors like drivers and restraints for market development. Future trends and opportunities in the global Genomics market have also been mentioned in the study.

Get Sample Copy of the Report @ https://www.theinsightpartners.com/sample/TIPTE100000730/?utm_source=openpr&utm_medium=10203

The genomics is defined as the study of a gene and its functioning. The concept of genomics is aimed to understand the architecture of the genome which is comprised of the deoxyribo nucleic acid (DNA), ribo nucleic acid (RNA) and proteins. Genomics is meant to examine the molecular mechanisms and the interaction of genetic and environmental factors in the diseases. The report would be of an interest to various stakeholders operating in the genomics market. These stakeholders include hospitals, research institutes, medical device suppliers, diagnostic centers, academic institutes, market research, equipment manufacturers, and consulting firms.

The major players operating in the genomics market include Thermo Fisher Scientific Inc., Illumina Inc., and Eurofins, Qiagen, Agilent Technologies, BGI, Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, Danaher, and GE Healthcare. For instance, in October 2018, Roche launched the three new next-generation sequencing (NGS) AVENIO Tumor Tissue Analysis Kits, the AVENIO Tumor Tissue Targeted Kit, Expanded Kit and Surveillance Kit. The kits detect all four mutation classes in solid tumours, complement Roche's NGS ctDNA kits for oncology research. The developments performed by the companies are helping the market to grow in the coming years.

Global genomics market, based on technology was segmented into sequencing, microarray, PCR, nucleic acid extraction and purification, and others. In 2017, sequencing segment held the largest share of the market, by technology. Moreover, the sequencing segment held the largest share of the market owing to its variant libraries, genes, operons, increase the function of proteins, and to test the particular gene. However, the microarray segment is expected to grow at the fastest rate during the coming years.

Purchase this Report @ https://www.theinsightpartners.com/buy/TIPTE100000730/?utm_source=openpr&utm_medium=10203

The report analyzes factors affecting genomics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key genomics manufacturing companies along with their SWOT analysis and market strategies.

Contact US:
Phone: +1-646-491-9876
Email Id: sam@theinsightpartners.com
Website: www.theinsightpartners.com

About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

This release was published on openPR.